Imaging Diagnostic Systems, Inc. (US OTC: IMDS) Has A Chart That Is Begging for a Breakout!
Happy Monday Mi Amors!
Your Senorita is taking another look at one muy caliente triple 0 stinker that just might be getting ready to break into the .001s. I’m talking about Imaging Diagnostic Systems (US OTC: IMDS) which many lucky rrroaches took for a 66% ride last month, and it seems while it is a little slow to brew when it comes to cracking the .0005s which is a PITA resistance, the chart is setting up for what could potentially be a big breakout.
For last month’s FUNdies on IMDS click here: http://www.stockroach.com/imaging-diagnostics-systems-us-otc-imds-is-looking-muy-roachy/
Since then accumulation has been through the roof as traders and investors jostle for shares of this bio-tech company that has a novel way of detecting breast cancer that can reduce unnecessary biopsies, and give a clearer image of healthy and malignant cells than the standard mammogram.
Here’s a quick technical update on what could be a monster play, and the charts are looking really nice right now.
Let’s pull up the chart for IMDS:
As you can see the accumulation is spiking and there is a slight divergence on the MACD which is an indicator that I personally like to rely on since a divergence on the MACD tends to signal EL TORO!
Support for IMDS comes in at .0003 with resistances lying ahead at .0005, and the 50 DMA of .0006. If IMDS can break and hold above the 50 DMA it should make a nice run to the .001 levels before hitting another resistance level.
You would most likely know how to spot the supports and early signs of breakout if you have read our 100% FREE E-BOOK! Wait? You haven’t read our e-book? For shame since it can teach you how to play these penny stocks like a fiddle instead of getting played by more saavy penny traders!
Click “Right Here” to DOWNLOAD your very own free copy of, “A bottom feeder’s guide to surviving penny stocks.”
Don’t forget to sign up to the StockRoach Twitter feed for heads up alerts and intraday plays!
The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach
This corporate profile is provided for information purposes only and should not
be used as the basis for any investment decision. We are neither licensed nor
qualified to provide investment advice. We were not paid, nor do we hold a
position in this stock. We reserve the right to buy or sell IMDS at any time
after this post.
1 Responses »
Leave a Response